Old Web
English
Sign In
Acemap
>
authorDetail
>
Corinne Woods
Corinne Woods
Food and Drug Administration
Internal medicine
Medicine
Population
Clinical trial
Idelalisib
3
Papers
16
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare Beneficiaries
2019
JAMA Oncology
Steven T. Bird
Fang Tian
Natasha Flowers
Donna Przepiorka
Rongrong Wang
Tae-Hyun Jung
Zebulin Kessler
Corinne Woods
Bo Kim
Barry W. Miller
Michael Wernecke
Clara Kim
Stephen McKean
Kate Gelperin
Thomas E. MaCurdy
Jeffrey A. Kelman
David J. Graham
Show All
Source
Cite
Save
Citations (15)
Idelalisib for Treatment of Follicular Lymphoma and Chronic Lymphocytic Leukemia in Clinical Trials Versus the Real World: Treatment Duration and Survival Are Associated with Pretreatment Modified Charlson Score
2018
Blood
Steven T. Bird
Natasha Flowers
Fang Tian
Donna Przepiorka
Tae-Hyun Jung
Rongrong Wang
Zebulin Kessler
Corinne Woods
Bo Kim
Barry W. Miller
Michael Wernecke
Stephen McKean
Clara Kim
Kate Gelperin
Jeffrey A. Kelman
David J. Graham
Show All
Source
Cite
Save
Citations (0)
Hydroxyurea Utilization Patterns Among Sickle Cell Disease Patients in the United States, US FDA Sentinel Database
2018
Blood
Rosanna Setse
Corinne Woods
Bindu Kanapuru
Talia J. Menzin
Justin Bohn
Justin Mathew
David Coyle
Barry W. Miller
Ann T. Farrell
Show All
Source
Cite
Save
Citations (1)
1